This review is a summary of evidence in support of lisdexamfetamine dimesilate use in patients with attention deficit hyperactivity disorder (ADHD).
Independent commentary has been provided by Dr Karin Proudman, staff specialist Developmental Paediatrician at Liverpool Hospital and within the Central Sydney Area Health Service.
Please login below to download this issue (PDF)